Announcements Trials
Browse Landscape

Phase

Phase 4 13Phase 2 5Phase 3 3Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 3Completed 3Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 2Pain 1Non Cancer Pain 1Cancer Pain 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Oxycodone × Clear all
NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT01675622 2018-05-21

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
242 enrolled 20 charts

Cancer Pain, Neoplasms

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
230 enrolled

Non Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡